GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Common Stock

Vicore Pharma Holding AB (OSTO:VICO) Common Stock : kr117.3 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Common Stock?

Vicore Pharma Holding AB's quarterly common stock stayed the same from Jun. 2024 (kr0.0 Mil) to Sep. 2024 (kr0.0 Mil) but then increased from Sep. 2024 (kr0.0 Mil) to Dec. 2024 (kr117.3 Mil).

Vicore Pharma Holding AB's annual common stock increased from Dec. 2022 (kr40.9 Mil) to Dec. 2023 (kr55.9 Mil) and increased from Dec. 2023 (kr55.9 Mil) to Dec. 2024 (kr117.3 Mil).


Vicore Pharma Holding AB Common Stock Historical Data

The historical data trend for Vicore Pharma Holding AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Common Stock Chart

Vicore Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.21 35.88 40.92 55.86 117.29

Vicore Pharma Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.86 - - - 117.29

Vicore Pharma Holding AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Vicore Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines